A Safety Study of Pentoxifylline for the Treatment of Anemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Raymond M. Hakim, MD, PhD
Fresenius Medical Care North America
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fresenius Medical Care North America
Chicago, Illinois, United States
- Fresenius Medical Care North America
Kalamazoo, Michigan, United States
- Fresenius Medical Care North America
Brookhaven, Mississippi, United States
- Fresenius Medical Care North America
Tupelo, Mississippi, United States
- Fresenius Medical Care North America
City of Saint Peters, Missouri, United States
- Fresenius Medical Care North America
Saint Ann, Missouri, United States
- Fresenius Medical Care North America
Las Vegas, Nevada, United States
- Fresenius Medical Care North America
Columbia, Tennessee, United States
- Fresenius Medical Care North America
Irving, Texas, United States
- Fresenius Medical Care North America
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2010
- Primary completion
- 31 Jan 2012
- Completion
- 31 Jan 2012
- Last update posted
- 28 Mar 2012
- Registered enrollment
- 48
- Registry id
- NCT01102218
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.